Online recruitment campaign for an influenza virus seasonal epidemic and pandemic... Tender

Procurement Summary

Country : USA

Summary : Online recruitment campaign for an influenza virus seasonal epidemic and pandemic Phase 1 study

Deadline : 03 Jan 2025

Other Information

Notice Type : Tender

TOT Ref.No.: 112358578

Document Ref. No. : NOI-NIAID-25-2251388

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Login to see details

Tender Details

Description

PRE-SOLICITATION NOTICE - NOTICE OF INTENT TO SOLE SOURCE

NOI-NIAID-25-2251388

NAICS - 541810, Advertising Agencies



This is a Notice of Intent, not a request for proposal. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with BuildClinical, LLC of New York, NY to procure an online recruitment campaign for an influenza virus seasonal epidemic and pandemic Phase 1 open-label, dose escalation study to evaluate the dose, safety, tolerability, and immunogenicity of mosaic hexavalent influenza vaccine VRC-FLUMOS0116-00-VP (FluMos-v2) with and without Army Liposome Formulation containing saponin QS-21 (ALFQ) adjuvant.

NIAID conducts many clinical trials at the NIH Clinical Center, America-s research hospital, which is located on the main campus in Bethesda, Maryland. NIAID conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. For more than 60 years, NIAID research has led to new therapies, vaccines, diagnostic tests, and other technologies that have improved the health of millions of people in the United States and around the world. NIAID conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. Influenza virus causes seasonal epidemics and pandemics at irregular intervals that result in significant morbidity and mortality. According to the World Health Organization (WHO) the annual epidemics result in 3 to 5 million cases of severe illness and about 290, 000 to 650, 000 respiratory deaths. The Center for Disease Control (CDC) estimates that during the 2019-2020 influenza season, there were 56 million illnesses, 26 million medical visits, 740, 000 hospitalizations, and 62, 000 deaths in the United States (US). Despite the annual i...
Active Contract Opportunity
Notice ID : NOI-NIAID-25-2251388
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : NATIONAL INSTITUTES OF HEALTH
Office: NATIONAL INSTITUTES OF HEALTH NIAID
General Information
Contract Opportunity Type: Presolicitation (Updated)
Updated Published Date: Dec 26, 2024 02:58 pm EST
Original Published Date: Dec 26, 2024 02:58 pm EST
Updated Response Date: Jan 03, 2025 05:00 pm EST
Original Response Date: Jan 03, 2025 05:00 pm EST
Inactive Policy: 15 days after response date
Updated Inactive Date: Jan 18, 2025
Original Inactive Date: Jan 18, 2025
Initiative: None

Classification
Original Set Aside:

Product Service Code: T099 - PHOTO/MAP/PRINT/PUBLICATION- OTHER
NAICS Code: 541810 - Advertising Agencies

Place of Performance: Bethesda, MD 20892 USA

Documents

 Tender Notice